Literature DB >> 2282465

The effects of (-)-daurisoline on Ca2+ influx in presynaptic nerve terminals.

Y M Lu1, G Q Liu.   

Abstract

1. The effects of (-)-daurisoline on 45Ca2+ uptake and [3H]-gamma-aminobutyric acid ([3H]-GABA) release from synaptosomes of rat cerebral cortex and on contractile activity of rat aorta were examined. 2. Application of (-)-daurisoline (1-100 microM) produced concentration-related inhibition of high K(+)-stimulated 45Ca2+ uptake and [3H]-GABA release (IC50 = 7.7 +/- 0.9 microM and 10.0 +/- 1.5 microM, respectively) in synaptosomes but verapamil was only weakly active. 3. Neither (-)-daurisoline (100 microM) nor verapamil (100 microM) modified 45Ca2+ uptake in control medium (5 mM K+, resting uptake) and [3H]-GABA release in Ca-free medium (45 mM K+ basal release). 4. High K+ and noradrenaline-evoked contractions of rat aorta were inhibited by both (-)-daurisoline and verapamil. 5. In conclusion, (-)-daurisoline, which differed from verapamil in its mode of blocking Ca2+ influx may be a potent Ca2+ antagonist of Ca2+ channels in neurones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282465      PMCID: PMC1917626          DOI: 10.1111/j.1476-5381.1990.tb12086.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The early time course of potassium-stimulated calcium uptake in presynaptic nerve terminals isolated from rat brain.

Authors:  D A Nachshen
Journal:  J Physiol       Date:  1985-04       Impact factor: 5.182

3.  Correlation of rates of calcium entry and endogenous dopamine release in mouse striatal synaptosomes.

Authors:  S W Leslie; J J Woodward; R E Wilcox
Journal:  Brain Res       Date:  1985-01-28       Impact factor: 3.252

4.  Pentobarbital depression of stimulus-secretion coupling in brain--selective inhibition of depolarization-induced calcium-dependent release.

Authors:  J W Haycock; W B Levy; C W Cotman
Journal:  Biochem Pharmacol       Date:  1977-01-15       Impact factor: 5.858

Review 5.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

6.  The effects of some organic "calcium antagonists" on calcium influx in presynaptic nerve terminals.

Authors:  D A Nachshen; M P Blaustein
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

7.  Initial release of [3H]dopamine from rat striatal synaptosomes: correlation with calcium entry.

Authors:  P Drapeau; M P Blaustein
Journal:  J Neurosci       Date:  1983-04       Impact factor: 6.167

8.  Effects of lead on neuromuscular transmission in the frog.

Authors:  R S Manalis; G P Cooper; S L Pomeroy
Journal:  Brain Res       Date:  1984-02-27       Impact factor: 3.252

9.  Effects of Pb2+ and Cd2+ on acetylcholine release and Ca2+ movements in synaptosomes and subcellular fractions from rat brain and Torpedo electric organ.

Authors:  J Suszkiw; G Toth; M Murawsky; G P Cooper
Journal:  Brain Res       Date:  1984-12-03       Impact factor: 3.252

10.  Some properties of potassium-stimulated calcium influx in presynaptic nerve endings.

Authors:  D A Nachshen; M P Blaustein
Journal:  J Gen Physiol       Date:  1980-12       Impact factor: 4.086

View more
  4 in total

1.  Effects of Ca2+ antagonists on glutamate release and Ca2+ influx in the hippocampus with in vivo intracerebral microdialysis.

Authors:  Y M Lu; J T Zhang; F Q Zhao; Y F Qin
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

2.  Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.

Authors:  P C Waldmeier; P Wicki; W Fröstl; H Bittiger; J J Feldtrauer; P A Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.

Authors:  M D Ivorra; C Lugnier; M Catret; E Anselmi; D Cortes; P D'Ocon
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

4.  Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines.

Authors:  S Chuliá; M D Ivorra; C Lugnier; E Vila; M A Noguera; P D'Ocon
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.